Literature DB >> 33350828

Membrane Permeability in Cyclic Peptides is Modulated by Core Conformations.

Flaviu Cipcigan1, Paul Smith1,2, Jason Crain1,3, Anders Hogner4, Leonardo De Maria5, Antonio Llinas6, Ekaterina Ratkova4.   

Abstract

Cyclic peptides have the potential to bind to challenging targets, which are undruggable with small molecules, but their application is limited by low membrane permeability. Here, using a series of cyclic pentapeptides, we showed that established physicochemical criteria of permeable peptides are heavily violated. We revealed that a dominant core conformation, stabilized by amides' shielding pattern, could guide the design of novel compounds. As a result, counter-intuitive strategies, such as incorporation of polar residues, can be beneficial for permeability. We further find that core globularity is a promising descriptor, which can extend the capability of standard predictive models.

Entities:  

Year:  2020        PMID: 33350828     DOI: 10.1021/acs.jcim.0c00803

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  3 in total

1.  Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space.

Authors:  Giulia Caron; Jan Kihlberg; Gilles Goetz; Ekaterina Ratkova; Vasanthanathan Poongavanam; Giuseppe Ermondi
Journal:  ACS Med Chem Lett       Date:  2021-01-05       Impact factor: 4.345

2.  Polar/apolar interfaces modulate the conformational behavior of cyclic peptides with impact on their passive membrane permeability.

Authors:  Stephanie M Linker; Christian Schellhaas; Benjamin Ries; Hans-Jörg Roth; Marianne Fouché; Stephane Rodde; Sereina Riniker
Journal:  RSC Adv       Date:  2022-02-16       Impact factor: 3.361

3.  Lipid Composition Is Critical for Accurate Membrane Permeability Prediction of Cyclic Peptides by Molecular Dynamics Simulations.

Authors:  Masatake Sugita; Takuya Fujie; Keisuke Yanagisawa; Masahito Ohue; Yutaka Akiyama
Journal:  J Chem Inf Model       Date:  2022-09-02       Impact factor: 6.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.